UPS to expedite pharma, AOG handling with new acquisition
In this article (4)
UPS has entered into an agreement with private equity firm Quad-C Management to acquire MNX Global Logistics (MNX), a time-critical logistics provider with clients in the aerospace, healthcare and pharma industries.
UPS will look to leverage MNX’s specialist capabilities in airport on ground (AOG) delivery services and temperature-controlled logistics for its healthcare unit and clinical trial logistics subsidiary Marken.
The company will also offer industry-leading time-critical, temperature-sensitive logistics services together with UPS Express Critical. The transaction is expected to close by year-end, subject to customary regulatory review and approval. UPS has not declared the value and terms of the transaction at the time of writing.
Questions & Answers
Q.Which specific industries are MNX Global Logistics' clients primarily from?
Which specific industries are MNX Global Logistics' clients primarily from?
MNX Global Logistics serves clients in the aerospace, healthcare, and pharmaceutical industries. This specialisation aligns with UPS's strategic goals for its healthcare unit and clinical trial logistics subsidiary.
Q.How will UPS utilise MNX's specialised capabilities after the acquisition?
How will UPS utilise MNX's specialised capabilities after the acquisition?
UPS plans to use MNX's expertise in airport on ground delivery services and temperature-controlled logistics. These capabilities will support UPS's healthcare unit and its clinical trial logistics subsidiary, Marken.
Q.When is the acquisition of MNX Global Logistics expected to be finalised?
When is the acquisition of MNX Global Logistics expected to be finalised?
The transaction is anticipated to close by the end of the current year. This is contingent on the completion of customary regulatory review and approval processes.
Reader pulse
Is this a smart acquisition for UPS?
21,184 votes so far